Cognitive behaviour therapy for excessive worry over health in medical patients

Conditions

Hypochondriasis/mental health Mental and Behavioural Disorders Somatoform disorders

Peter Tyrer, Duolao Wang, Mike Crawford, Simon Dupont, Sylvia Cooper et al. (9 authors)

Psychological Medicine2020-03-1621 citations

10.1017/s003329172000046x

Cognitive-behaviour therapy for health anxiety in medical patients (CHAMP): a randomised controlled trial with outcomes to 5 years.

Tyrer P, Salkovskis P, Tyrer H, Wang D, Crawford MJ, Dupont S, Cooper S, Green J, Murphy D, Smith G, Bhogal S, Nourmand S, Lazarevic V, Loebenberg G, Evered R, Kings S, McNulty A, Lisseman-Stones Y, McAllister S, Kramo K, Nagar J, Reid S, Sanatinia R, Whittamore K, Walker G, Philip A, Warwick H, Byford S, Barrett B.

2017-09-0128 citations

10.3310/hta21500

Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: a multicentre randomised controlled trial.

Tyrer P, Cooper S, Salkovskis P, Tyrer H, Crawford M, Byford S, Dupont S, Finnis S, Green J, McLaren E, Murphy D, Reid S, Smith G, Wang D, Warwick H, Petkova H, Barrett B.

2013-10-1891 citations

10.1016/s0140-6736(13)61905-4

CHAMP: Cognitive behaviour therapy for health anxiety in medical patients, a randomised controlled trial.

Tyrer P, Cooper S, Tyrer H, Salkovskis P, Crawford M, Green J, Smith G, Reid S, Dupont S, Murphy D, Byford S, Wang D, Barrett B.

2011-06-1423 citations

10.1186/1471-244x-11-99

Interventions

Arm 1: Cognitive behaviour therapy adapted for health anxiety (Warwick/Salkovskis model). Treatment will be given for between 5 and 10 one hour sessions for each patient, and will address abnormal wor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients attending four medical specialty clinics (in cardiology, respiratory medicine, gastroenterology and endocrinology) who: 1. Have significant health anxiety (score of 20 or more on the Health Anxiety Inventory) 2. Are aged between 16 and 75 (both males and females) 3. Are living independently 4. Are permanent residents in the area 5. Have sufficient understanding of English to read and complete the questionnaires 6. Give written consent for the interviews, including audiotaping of half the sessions 7. Give written consent for access to their medical records

Exclusion criteria

Exclusion criteria: Patients who are: 1. Considered too ill in medical terms by their consultants to be considered for the study 2. In the process of being investigated for significant pathology and for whom cognitive behaviour therapy might confuse or cause distress 3. Those who have significant cognitive impairment

Design outcomes

Primary

Measure	Time frame
Reduction in health anxiety scores 1 year after randomisation.	—

Secondary

Measure	Time frame
1. Reduction in health anxiety scores 2 years after randomisation 2. Presence or absence of diagnosis of hypochondriasis at 1 and 2 years after randomisation 3. Reduction in generalised anxiety and depression, assessed using the Hospital Anxiety and Depression Scale (HADS) at 1 and 2 years after randomisation 4. Improvement in social function and quality of life, assessed using the Social Functioning Questionnaire (SFQ) and Euroqol EQ-5D at 1 and 2 years after randomisation 5. Total costs of health care (primary and secondary) 1 and 2 years after randomisation 6. Change in presenteeism and absenteeism at work 1 and 2 years after randomisation	—

Measure

Time frame

1. Reduction in health anxiety scores 2 years after randomisation 2. Presence or absence of diagnosis of hypochondriasis at 1 and 2 years after randomisation 3. Reduction in generalised anxiety and depression, assessed using the Hospital Anxiety and Depression Scale (HADS) at 1 and 2 years after randomisation 4. Improvement in social function and quality of life, assessed using the Social Functioning Questionnaire (SFQ) and Euroqol EQ-5D at 1 and 2 years after randomisation 5. Total costs of health care (primary and secondary) 1 and 2 years after randomisation 6. Change in presenteeism and absenteeism at work 1 and 2 years after randomisation

—

Countries

United Kingdom

Outcome results

None listed